Free Trial
NASDAQ:CAPS

Capstone (CAPS) Stock Price, News & Analysis

Capstone logo
$1.88 -0.01 (-0.53%)
As of 06/17/2025 04:00 PM Eastern

About Capstone Stock (NASDAQ:CAPS)

Key Stats

Today's Range
$1.86
$1.97
50-Day Range
$1.66
$2.90
52-Week Range
$1.58
$16.18
Volume
42,887 shs
Average Volume
75,239 shs
Market Capitalization
$300.80 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Will I be blacklisted?
The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washington… even Trump’s obsession with seizing Greenland. There’s a singular force that connects the dots… And it could threaten to transform American life – and your wealth – forever.
A capstone project
Capstone Holding Corp. (J7W.F)
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone's stock was trading at $2.40 at the start of the year. Since then, CAPS stock has decreased by 21.7% and is now trading at $1.88.
View the best growth stocks for 2025 here
.

Capstone (CAPS) raised $5 million in an IPO on Thursday, March 6th 2025. The company issued 1,250,000 shares at a price of $4.00 per share.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CAPS
Web
N/A
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.42 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$297.04 thousand
Optionable
N/A
Beta
-0.83
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CAPS) was last updated on 6/18/2025 by MarketBeat.com Staff
From Our Partners